| Lung Adenocarcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 55show all (up to 200) |
|---|
| → investigated in trials for | Carboplatinsmall molecule 20 trials (7 active) · roll-up of the cancer and its descendants | — | — | Lung Adenocarcinoma | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall molecule 18 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lung Adenocarcinoma | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 15 trials (4 active) · roll-up of the cancer and its descendants | — | — | Lung Adenocarcinoma | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemetrexedsmall_molecule 15 trials (4 active) · roll-up of the cancer and its descendants | — | — | Lung Adenocarcinoma | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 13 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lung Adenocarcinoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal_antibody 9 trials (5 active) · roll-up of the cancer and its descendants | — | — | Lung Adenocarcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal_antibody 8 trials (5 active) · roll-up of the cancer and its descendants | — | — | Lung Adenocarcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall molecule 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Adenocarcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinib Hydrochloridesmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Adenocarcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gefitinibsmall_molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Adenocarcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinibsmall_molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bortezomibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cetuximabmonoclonal antibody 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |